APEC starts down long road to regulatory convergence for medical products
This article was originally published in Scrip
Countries around the Pacific rim have formally adopted a strategic framework that lays out a roadmap towards the convergence of regulatory procedures for medical products by 2020, a breakthrough heralded as a "landmark achievement" by one leading figure in the pharma industry.
You may also be interested in...
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.
Join us for a brief audio roundup of the major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Japanese major builds presence in novel device technology beyond its conventional therapeutics as looks towards a more holistic future of care.